"One is purpose built for the ICU, with limited portability, and the other can be applied in numerous clinical, emergency and research settings on land, sea and air"
The ICU is one of of the purposes for Hyperfine. There are also other in hospital uses.
When you say "the other can be applied in numerous clinical, emergency and research settings on land, sea and air" you appear to be referring to EMV's Gen 2 device. I never suggested that Hyperfine could be a competitor with the Gen 2 device. In fact, I said the opposite.
The competition is with Gen 1 because they both have an 'in hospital' focus on brain imaging for situations where it is too dangerous, untimely or too inconvenient to wheel patients to the central MRI/CT unit.
EMvision Research Notes, page-1721
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.050(2.38%) |
Mkt cap ! $175.1M | |||
| Open | High | Low | Value | Volume |
| $2.07 | $2.15 | $2.02 | $157.4K | 75.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3011 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 1629 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |